184 related articles for article (PubMed ID: 2338145)
1. Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.
Baumgart E; Völkl A; Pill J; Fahimi HD
FEBS Lett; 1990 May; 264(1):5-9. PubMed ID: 2338145
[TBL] [Abstract][Full Text] [Related]
2. The short- and long-term effects of bezafibrate in the rat.
Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
[TBL] [Abstract][Full Text] [Related]
3. Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal fatty acid oxidation-related enzymes by hypolipidemic peroxisome proliferators.
Watanabe T; Okawa S; Itoga H; Imanaka T; Suga T
Biochim Biophys Acta; 1992 Apr; 1135(1):84-90. PubMed ID: 1591274
[TBL] [Abstract][Full Text] [Related]
4. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation.
Brandes R; Kaikaus RM; Lysenko N; Ockner RK; Bass NM
Biochim Biophys Acta; 1990 Apr; 1034(1):53-61. PubMed ID: 2328261
[TBL] [Abstract][Full Text] [Related]
5. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
Reddy MK; Lalwani ND; Qureshi SA; Reddy JK
Hum Toxicol; 1982 Mar; 1(2):135-47. PubMed ID: 7173894
[TBL] [Abstract][Full Text] [Related]
6. Selective induction of peroxisomal enzymes by the hypolipidemic drug bezafibrate. Detection of modulations by automatic image analysis in conjunction with immunoelectron microscopy and immunoblotting.
Beier K; Völkl A; Hashimoto T; Fahimi HD
Eur J Cell Biol; 1988 Aug; 46(3):383-93. PubMed ID: 2903052
[TBL] [Abstract][Full Text] [Related]
7. The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes.
Blaauboer BJ; van Holsteijn CW; Bleumink R; Mennes WC; van Pelt FN; Yap SH; van Pelt JF; van Iersel AA; Timmerman A; Schmid BP
Biochem Pharmacol; 1990 Aug; 40(3):521-8. PubMed ID: 2383284
[TBL] [Abstract][Full Text] [Related]
8. Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.
Pill J; Völkl A; Hartig F; Fahimi HD
Arch Toxicol; 1992; 66(5):327-33. PubMed ID: 1610295
[TBL] [Abstract][Full Text] [Related]
9. Alkylthio acetic acids (3-thia fatty acids)--a new group of non-beta-oxidizable peroxisome-inducing fatty acid analogues--II. Dose-response studies on hepatic peroxisomal- and mitochondrial changes and long-chain fatty acid metabolizing enzymes in rats.
Berge RK; Aarsland A; Kryvi H; Bremer J; Aarsaether N
Biochem Pharmacol; 1989 Nov; 38(22):3969-79. PubMed ID: 2574577
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral administration of bezafibrate on peroxisomes and carnitine acetyltransferase in rat hepatocytes.
Ohue M; Makita T
J Vet Med Sci; 1994 Jun; 56(3):541-6. PubMed ID: 7948386
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
[TBL] [Abstract][Full Text] [Related]
12. Alkylthioacetic acids (3-thia fatty acids) as non-beta-oxidizable fatty acid analogues: a new group of hypolipidemic drugs. III. Dissociation of cholesterol- and triglyceride-lowering effects and the induction of peroxisomal beta-oxidation.
Aarsland A; Aarsaether N; Bremer J; Berge RK
J Lipid Res; 1989 Nov; 30(11):1711-8. PubMed ID: 2614273
[TBL] [Abstract][Full Text] [Related]
13. Induction of fatty acid beta-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agent.
Lalwani ND; Reddy MK; Ghosh S; Barnard SD; Molello JA; Reddy JK
Biochem Pharmacol; 1985 Oct; 34(19):3473-82. PubMed ID: 3840374
[TBL] [Abstract][Full Text] [Related]
14. The effect of bezafibrate and long-chain fatty acids on peroxisomal activities in cultured rat hepatocytes.
Hertz R; Arnon J; Bar-Tana J
Biochim Biophys Acta; 1985 Sep; 836(2):192-200. PubMed ID: 2992600
[TBL] [Abstract][Full Text] [Related]
15. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
Lazarow PB; Shio H; Leroy-Houyet MA
J Lipid Res; 1982 Feb; 23(2):317-26. PubMed ID: 7077146
[TBL] [Abstract][Full Text] [Related]
16. Microsomal and cytosolic epoxide hydrolases, the peroxisomal fatty acid beta-oxidation system and catalase. Activities, distribution and induction in rat liver parenchymal and non-parenchymal cells.
Steinberg P; Schladt L; Dienes HP; Timms C; Oesch F
Eur J Biochem; 1988 Sep; 176(1):39-45. PubMed ID: 3416872
[TBL] [Abstract][Full Text] [Related]
17. Peroxisomal fatty acid oxidation as detected by H2O2 production in intact perfused rat liver.
Foerster EC; Fährenkemper T; Rabe U; Graf P; Sies H
Biochem J; 1981 Jun; 196(3):705-12. PubMed ID: 7317011
[TBL] [Abstract][Full Text] [Related]
18. Induction of hepatic peroxisomes by a new, non-carboxylate-containing drug, bifonazole.
Horie S; Fukumori N; Suga T
Toxicol Lett; 1991 Mar; 55(3):249-54. PubMed ID: 2003267
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine.
Gerondaes P; Alberti KG; Agius L
Biochem J; 1988 Jul; 253(1):161-7. PubMed ID: 3048253
[TBL] [Abstract][Full Text] [Related]
20. Glucagon and fasting do not activate peroxisomal fatty acid beta-oxidation in rat liver.
Slauter RW; Yamazaki RK
Arch Biochem Biophys; 1984 Aug; 233(1):197-202. PubMed ID: 6540549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
